NEDD4L and non-small cell lung carcinoma: In NSCLC, NEDD4L can mediate the ubiquitination and downregulation of PD-L1, increasing the proportion of CD8+ T cells and the content of IL-2 and INF-γ (Zhong et al., 2022).